[治疗和照顾老年癌症患者的独特挑战]。

Q3 Nursing Journal of Nursing Pub Date : 2024-12-01 DOI:10.6224/JN.202412_71(6).01
Yuan-Yuan Fang
{"title":"[治疗和照顾老年癌症患者的独特挑战]。","authors":"Yuan-Yuan Fang","doi":"10.6224/JN.202412_71(6).01","DOIUrl":null,"url":null,"abstract":"<p><p>In older age, tissue degeneration, decreased cellular competition, and the declining efficiency of clearance mechanisms lead to higher rates of survival and accumulation for cells with adaptive mutations, which increase the risk of cancer cell development (Laconi et al., 2020). Thus, age is a significant risk factor for cancer. It is projected that by 2050, the global population aged 60 and above will rise to 2.1 billion, with those aged 80 and above expected to reach 426 million (World Health Organization, 2024). Taiwan, which became an aging society in 2018, is expected to be a nation in which older adults constitute 46.5% of the total population by 2070 (National Development Council, 2024). As the older adult population increases, the number of patients with cancer will also almost certainly continue to rise. Older adults respond differently to traditional cancer treatments than younger individuals, often experiencing declines in physical function, frailty, and cognitive impairment (Extermann, 2000). Moreover, older adult patients frequently have multiple chronic diseases (e.g., cardiovascular disease, diabetes, pulmonary, renal, liver diseases) that increase the complexity and risks associated with cancer treatment (Dale et al., 2012). They may also use over-the-counter medications or herbal supplements in addition to prescription drugs (Maggiore et al., 2010), which raises the risk of treatment toxicity and complications, presenting challenges for treatment decision-making. According to a survey by the National Cancer Institute, only 32% of patients with cancer participating in clinical trials were over 65 years old (Murthy et al., 2004). This may relate to the common exclusion of patients with comorbidities, physician attitudes, and/or the lower willingness of older adult patients to participate (Lewis et al., 2003). Thus, existing data may be insufficient to support the development of optimal treatment plans for older adult patients with cancer (Dale et al., 2012; Extermann, 2000). Age discrimination may lead to undertreatment or overtreatment, affecting patients' functional status and quality of life (Extermann, 2000; Hamaker et al., 2022). Currently, most oncology research relies on either the Eastern Cooperative Oncology Group performance status scale or Karnofsky Performance Scale to assess health status. However, neither adequately differentiates for the characteristics of older adult patients (Pal et al., 2010). In assessing quality of life in patients with cancer, the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire or Medical Outcomes Study 36-item Short Form Health Survey is commonly used. However, these tools lack targeted assessments for cognitive function, activities of daily living, and autonomy (such as cooking, shopping, making phone calls, and managing finances), which are issues of particular concern in older adult patients (Terret et al., 2011). The American Society of Clinical Oncology recommends that older adult cancer care should include geriatric assessments (GAs) of key elements such as functional status, mental health, cognitive ability, nutritional status, chemotherapy toxicity risks, life expectancy, comorbidities, fall history, and social support to provide critical reference data for treatment planning (Chapman et al., 2021; Dale et al., 2023; Hamaker et al., 2022). However, a randomized controlled trial showed that GAs do not significantly improve physical function or quality of life for older adult patients with cancer, suggesting the benefits of these assessments remain unclear (Portielje & van den Bos, 2024). Nevertheless, other studies have shown that GAs significantly reduce chemotherapy toxicity and improve satisfaction among patients and their families (Dale et al., 2023). Despite these recommendations, knowledge of geriatric oncology has not been widely integrated into medical training, and GAs have not been incorporated into clinical care processes (Chapman et al., 2021; Diaz et al., 2024), highlighting a global healthcare system lacking the expertise and skills necessary to provide appropriate targeted care for older adult patients with cancer. Given the increasing importance of geriatric cancer care, this column provides an in-depth exploration of the care needs of older adult patients with cancer, treatment decision-making, cognitive impairment issues, and the burdens faced by family caregivers. The four articles within are geared toward enhancing the knowledge and skills of nursing professionals in geriatric oncology care and, ultimately, improving the quality of care provided to older adult patients with cancer.</p>","PeriodicalId":35672,"journal":{"name":"Journal of Nursing","volume":"71 6","pages":"4-7"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[The Unique Challenges of Treating and Caring for Older Adult Patients With Cancer].\",\"authors\":\"Yuan-Yuan Fang\",\"doi\":\"10.6224/JN.202412_71(6).01\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In older age, tissue degeneration, decreased cellular competition, and the declining efficiency of clearance mechanisms lead to higher rates of survival and accumulation for cells with adaptive mutations, which increase the risk of cancer cell development (Laconi et al., 2020). Thus, age is a significant risk factor for cancer. It is projected that by 2050, the global population aged 60 and above will rise to 2.1 billion, with those aged 80 and above expected to reach 426 million (World Health Organization, 2024). Taiwan, which became an aging society in 2018, is expected to be a nation in which older adults constitute 46.5% of the total population by 2070 (National Development Council, 2024). As the older adult population increases, the number of patients with cancer will also almost certainly continue to rise. Older adults respond differently to traditional cancer treatments than younger individuals, often experiencing declines in physical function, frailty, and cognitive impairment (Extermann, 2000). Moreover, older adult patients frequently have multiple chronic diseases (e.g., cardiovascular disease, diabetes, pulmonary, renal, liver diseases) that increase the complexity and risks associated with cancer treatment (Dale et al., 2012). They may also use over-the-counter medications or herbal supplements in addition to prescription drugs (Maggiore et al., 2010), which raises the risk of treatment toxicity and complications, presenting challenges for treatment decision-making. According to a survey by the National Cancer Institute, only 32% of patients with cancer participating in clinical trials were over 65 years old (Murthy et al., 2004). This may relate to the common exclusion of patients with comorbidities, physician attitudes, and/or the lower willingness of older adult patients to participate (Lewis et al., 2003). Thus, existing data may be insufficient to support the development of optimal treatment plans for older adult patients with cancer (Dale et al., 2012; Extermann, 2000). Age discrimination may lead to undertreatment or overtreatment, affecting patients' functional status and quality of life (Extermann, 2000; Hamaker et al., 2022). Currently, most oncology research relies on either the Eastern Cooperative Oncology Group performance status scale or Karnofsky Performance Scale to assess health status. However, neither adequately differentiates for the characteristics of older adult patients (Pal et al., 2010). In assessing quality of life in patients with cancer, the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire or Medical Outcomes Study 36-item Short Form Health Survey is commonly used. However, these tools lack targeted assessments for cognitive function, activities of daily living, and autonomy (such as cooking, shopping, making phone calls, and managing finances), which are issues of particular concern in older adult patients (Terret et al., 2011). The American Society of Clinical Oncology recommends that older adult cancer care should include geriatric assessments (GAs) of key elements such as functional status, mental health, cognitive ability, nutritional status, chemotherapy toxicity risks, life expectancy, comorbidities, fall history, and social support to provide critical reference data for treatment planning (Chapman et al., 2021; Dale et al., 2023; Hamaker et al., 2022). However, a randomized controlled trial showed that GAs do not significantly improve physical function or quality of life for older adult patients with cancer, suggesting the benefits of these assessments remain unclear (Portielje & van den Bos, 2024). Nevertheless, other studies have shown that GAs significantly reduce chemotherapy toxicity and improve satisfaction among patients and their families (Dale et al., 2023). Despite these recommendations, knowledge of geriatric oncology has not been widely integrated into medical training, and GAs have not been incorporated into clinical care processes (Chapman et al., 2021; Diaz et al., 2024), highlighting a global healthcare system lacking the expertise and skills necessary to provide appropriate targeted care for older adult patients with cancer. Given the increasing importance of geriatric cancer care, this column provides an in-depth exploration of the care needs of older adult patients with cancer, treatment decision-making, cognitive impairment issues, and the burdens faced by family caregivers. The four articles within are geared toward enhancing the knowledge and skills of nursing professionals in geriatric oncology care and, ultimately, improving the quality of care provided to older adult patients with cancer.</p>\",\"PeriodicalId\":35672,\"journal\":{\"name\":\"Journal of Nursing\",\"volume\":\"71 6\",\"pages\":\"4-7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Nursing\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.6224/JN.202412_71(6).01\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Nursing\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nursing","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.6224/JN.202412_71(6).01","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Nursing","Score":null,"Total":0}
引用次数: 0

摘要

随着年龄的增长,组织退化、细胞竞争减少以及清除机制效率的下降导致适应性突变细胞的存活率和积累率提高,从而增加了癌细胞发展的风险(Laconi等人,2020)。因此,年龄是癌症的重要风险因素。预计到2050年,全球60岁及以上人口将增加到21亿,80岁及以上人口预计将达到4.26亿(世界卫生组织,2024年)。台湾在2018年进入老龄化社会,预计到2070年,老年人口将占总人口的46.5%(国家发展委员会,2024年)。随着老年人口的增加,癌症患者的数量也几乎肯定会继续上升。老年人对传统癌症治疗的反应与年轻人不同,他们经常经历身体功能下降、虚弱和认知障碍(Extermann, 2000)。此外,老年患者经常患有多种慢性疾病(如心血管疾病、糖尿病、肺病、肾病、肝病),这增加了癌症治疗的复杂性和风险(Dale等,2012)。除了处方药外,他们还可能使用非处方药或草药补充剂(Maggiore et al., 2010),这增加了治疗毒性和并发症的风险,对治疗决策提出了挑战。根据美国国家癌症研究所的一项调查,参加临床试验的癌症患者中,年龄在65岁以上的只有32% (Murthy et al., 2004)。这可能与通常排除有合并症的患者、医生态度和/或老年患者参与意愿较低有关(Lewis et al., 2003)。因此,现有数据可能不足以支持为老年癌症患者制定最佳治疗方案(Dale et al., 2012;Extermann, 2000)。年龄歧视可能导致治疗不足或过度治疗,影响患者的功能状态和生活质量(Extermann, 2000;Hamaker et al., 2022)。目前,大多数肿瘤研究依赖于东方肿瘤合作小组绩效状态量表或Karnofsky绩效量表来评估健康状况。然而,两者都不能充分区分老年患者的特征(Pal et al., 2010)。在评估癌症患者的生活质量时,通常使用欧洲癌症研究和治疗组织的核心生活质量问卷或医疗结果研究36项简短健康调查。然而,这些工具缺乏对认知功能、日常生活活动和自主性(如烹饪、购物、打电话和管理财务)的针对性评估,这些都是老年患者特别关注的问题(Terret et al., 2011)。美国临床肿瘤学会建议,老年人癌症护理应包括功能状态、心理健康、认知能力、营养状况、化疗毒性风险、预期寿命、合并症、跌倒史和社会支持等关键要素的老年评估(GAs),为治疗计划提供关键参考数据(Chapman等,2021;Dale et al., 2023;Hamaker et al., 2022)。然而,一项随机对照试验显示,气体并不能显著改善老年癌症患者的身体功能或生活质量,这表明这些评估的益处尚不清楚(Portielje & van den Bos, 2024)。然而,其他研究表明,气体显著降低化疗毒性,提高患者及其家属的满意度(Dale et al., 2023)。尽管有这些建议,但老年肿瘤学知识尚未广泛纳入医学培训,GAs尚未纳入临床护理流程(Chapman等,2021;Diaz等人,2024),强调全球医疗保健系统缺乏必要的专业知识和技能,无法为老年癌症患者提供适当的有针对性的护理。鉴于老年癌症护理的重要性日益增加,本专栏将深入探讨老年癌症患者的护理需求、治疗决策、认知障碍问题以及家庭护理人员面临的负担。这四篇文章旨在提高老年肿瘤护理专业人员的知识和技能,并最终提高为老年癌症患者提供的护理质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[The Unique Challenges of Treating and Caring for Older Adult Patients With Cancer].

In older age, tissue degeneration, decreased cellular competition, and the declining efficiency of clearance mechanisms lead to higher rates of survival and accumulation for cells with adaptive mutations, which increase the risk of cancer cell development (Laconi et al., 2020). Thus, age is a significant risk factor for cancer. It is projected that by 2050, the global population aged 60 and above will rise to 2.1 billion, with those aged 80 and above expected to reach 426 million (World Health Organization, 2024). Taiwan, which became an aging society in 2018, is expected to be a nation in which older adults constitute 46.5% of the total population by 2070 (National Development Council, 2024). As the older adult population increases, the number of patients with cancer will also almost certainly continue to rise. Older adults respond differently to traditional cancer treatments than younger individuals, often experiencing declines in physical function, frailty, and cognitive impairment (Extermann, 2000). Moreover, older adult patients frequently have multiple chronic diseases (e.g., cardiovascular disease, diabetes, pulmonary, renal, liver diseases) that increase the complexity and risks associated with cancer treatment (Dale et al., 2012). They may also use over-the-counter medications or herbal supplements in addition to prescription drugs (Maggiore et al., 2010), which raises the risk of treatment toxicity and complications, presenting challenges for treatment decision-making. According to a survey by the National Cancer Institute, only 32% of patients with cancer participating in clinical trials were over 65 years old (Murthy et al., 2004). This may relate to the common exclusion of patients with comorbidities, physician attitudes, and/or the lower willingness of older adult patients to participate (Lewis et al., 2003). Thus, existing data may be insufficient to support the development of optimal treatment plans for older adult patients with cancer (Dale et al., 2012; Extermann, 2000). Age discrimination may lead to undertreatment or overtreatment, affecting patients' functional status and quality of life (Extermann, 2000; Hamaker et al., 2022). Currently, most oncology research relies on either the Eastern Cooperative Oncology Group performance status scale or Karnofsky Performance Scale to assess health status. However, neither adequately differentiates for the characteristics of older adult patients (Pal et al., 2010). In assessing quality of life in patients with cancer, the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire or Medical Outcomes Study 36-item Short Form Health Survey is commonly used. However, these tools lack targeted assessments for cognitive function, activities of daily living, and autonomy (such as cooking, shopping, making phone calls, and managing finances), which are issues of particular concern in older adult patients (Terret et al., 2011). The American Society of Clinical Oncology recommends that older adult cancer care should include geriatric assessments (GAs) of key elements such as functional status, mental health, cognitive ability, nutritional status, chemotherapy toxicity risks, life expectancy, comorbidities, fall history, and social support to provide critical reference data for treatment planning (Chapman et al., 2021; Dale et al., 2023; Hamaker et al., 2022). However, a randomized controlled trial showed that GAs do not significantly improve physical function or quality of life for older adult patients with cancer, suggesting the benefits of these assessments remain unclear (Portielje & van den Bos, 2024). Nevertheless, other studies have shown that GAs significantly reduce chemotherapy toxicity and improve satisfaction among patients and their families (Dale et al., 2023). Despite these recommendations, knowledge of geriatric oncology has not been widely integrated into medical training, and GAs have not been incorporated into clinical care processes (Chapman et al., 2021; Diaz et al., 2024), highlighting a global healthcare system lacking the expertise and skills necessary to provide appropriate targeted care for older adult patients with cancer. Given the increasing importance of geriatric cancer care, this column provides an in-depth exploration of the care needs of older adult patients with cancer, treatment decision-making, cognitive impairment issues, and the burdens faced by family caregivers. The four articles within are geared toward enhancing the knowledge and skills of nursing professionals in geriatric oncology care and, ultimately, improving the quality of care provided to older adult patients with cancer.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Nursing
Journal of Nursing Medicine-Medicine (all)
CiteScore
0.80
自引率
0.00%
发文量
14
期刊最新文献
[Aging and Gender: Inclusive Care Practices and Policies for Lesbian, Gay, Bisexual and Transgender Older Adults]. [Age-Friendly Health Care: An Example of Providing Integrated Care for Older People (ICOPE) in Pingtung County, Taiwan]. [Application of Home Blood Pressure Monitoring in Hypertension Management]. [Using Therapeutic Play to Increase the Oral Administration Adherence Rate of Preschool Pediatric Inpatients]. [Development and Application of Family Management in Nursing Care].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1